National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/17/2021 release of VAERS data:

Found 13,148 cases where Vaccine is COVID19 and Manufacturer is PFIZER/BIONTECH and Symptom is Cerebral venous sinus thrombosis or Cerebral venous thrombosis or Coagulopathy or Deep vein thrombosis or Disseminated intravascular coagulation or Embolism or Idiopathic thrombocytopenic purpura or Immune thrombocytopenia or Immune thrombocytopenic purpura or Ischaemic stroke or Myocardial infarction or Petechiae or Pulmonary embolism or Purpura or Thrombocytopenia or Thrombosis or Vasculitis



Case Details

This is page 10 out of 1,315

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19   next


VAERS ID: 959017 (history)  
Form: Version 2.0  
Age: 41.0  
Sex: Female  
Location: Vermont  
Vaccinated:2021-01-08
Onset:2021-01-15
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-01-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK9231 / 2 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Chest X-ray abnormal, Chest pain, Immune thrombocytopenia, Immunoglobulin therapy, Platelet count decreased, Pulmonary hilar enlargement, Purpura, Rash
SMQs:, Anaphylactic reaction (broad), Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Systemic lupus erythematosus (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: melatonin 3mg daily, magnesium 500mg daily, gabapentin 300mg BID
Current Illness: none known.
Preexisting Conditions: lower extremity neuropathy
Allergies: meperidine = hives/dyspnea
Diagnostic Lab Data: Upon arrival to ED on 1/15 patient had CXR and blood work ordered. CXR showed hilar prominence and thickening paratracheal strip - recommended to get chest CT. Labwork revealed extremely low level of platelets, 11,000. Discussed with hematology who concurred it was probably ITP. Advised to admit patient, start prednisone 1 mg/kg/day and IVIG 1 g/kg/day x 2 days. On 1/16 platelets increased to 42,000 and on 1/17 they were 104,000. Patient responded well to treatment and was discharged on 1/17. At discharge plan for a slow taper of prednisosone over 4-6 weeks, weekly CBC''s and PCP prophylaxis with Bactrim. She was advised to f/u with PCP in 1 week and should consider getting lung lesion biopsy when platelet count allows.
CDC Split Type:

Write-up: Patient got her 2nd dose of Pfizer covid vaccine on 1/8. On 1/11 she had intermittent chest pain that lasted a few days and started to notice small purpura rash on left breast. She didn''t think much of it but noticed the same type of rash on her pant line and then right thigh. On 1/15 she called Occupational Health who advised her to go straight to the ED.


VAERS ID: 959401 (history)  
Form: Version 2.0  
Age: 36.0  
Sex: Male  
Location: Oklahoma  
Vaccinated:2020-12-30
Onset:2021-01-01
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-01-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK-5730 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Catheter placement, Chest X-ray, Computerised tomogram thorax abnormal, Cough, Dyspnoea, Echocardiogram normal, Electrocardiogram normal, Intensive care, Loss of consciousness, Pulmonary embolism, SARS-CoV-2 test negative, Ultrasound Doppler
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Embolic and thrombotic events, venous (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypoglycaemia (broad), COVID-19 (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Multivitamin
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: EKG and Echo Covid tests negative on 1/13/2021 and repeat 1/14/2021 CT Chest - positive for multiple pulmonary embolus CXR US Doppler lower/upper limbs
CDC Split Type:

Write-up: I was having episodes of dyspnea and non productive cough starting from 1/1/2021. On 1/13/2021 I experienced severe dyspnea and had loss of consciousness for 5 seconds and was found down. I was rushed to the hospital and diagnosed with multiple pulmonary embolus (about 9) which was treated with direct TPA via catheterization. I then recovered in the ICU and transitioned to oral anticoagulation and discharged home on 1/15/2021.


VAERS ID: 959469 (history)  
Form: Version 2.0  
Age: 31.0  
Sex: Female  
Location: Iowa  
Vaccinated:2021-01-12
Onset:2021-01-15
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-01-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL0142 / 2 LA / IM

Administered by: Work       Purchased by: ?
Symptoms: Computerised tomogram, Fatigue, Malaise, Pain in extremity, Pyrexia, Thrombosis, Ultrasound Doppler, Ultrasound scan
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies: NKA
Diagnostic Lab Data: Dopplers, Ultrasound, CT scan
CDC Split Type:

Write-up: Employee received her 2nd Pfizer vaccine on 1/12/2021. Twelve hours later she developed a fever with a T-max of 102 degrees. The fever lasted 18 hours. She also complained of severe malaise and fatigue lasting 36 hours. On day 3 she developed left lower extremity pain that persisted over the weekend. She was seen in Urgent Care today where she was diagnosed with a thrombosis. She also came to the ETC and was ruled out for a PE The employee does have a family history of antiphospholipid in her mother. She has a follow up with her PCP and will also receive a work up in hematology as she had never been tested for any genetic coagulation conditions after her mom''s diagnosis.


VAERS ID: 959470 (history)  
Form: Version 2.0  
Age: 72.0  
Sex: Female  
Location: Michigan  
Vaccinated:2021-01-20
Onset:2021-01-20
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-01-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL3249 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Brain natriuretic peptide normal, Chest pain, Computerised tomogram, Discomfort, Fatigue, Fibrin D dimer increased, Full blood count normal, Hyperhidrosis, International normalised ratio normal, Lipase increased, Metabolic function test normal, Myalgia, Pain in jaw, Pallor, Pulmonary embolism, Troponin normal
SMQs:, Rhabdomyolysis/myopathy (broad), Acute pancreatitis (broad), Haemorrhage laboratory terms (broad), Neuroleptic malignant syndrome (broad), Embolic and thrombotic events, venous (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Osteonecrosis (broad), Hypotonic-hyporesponsive episode (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: CELEBREX 200 MG ONE DAILY PRN PERCOCET 5/325 MG ONE -TWO TABS Q 4-6 HRS PRN VITAMIN D 2000 UNITS DAILY ZINC 50 MG DAILY CYMBALTA 60 MG DAILY
Current Illness: TOTAL KNEE REPLACEMENT X 2 WEEKS AGO
Preexisting Conditions: Bilateral breast cancer (HCC) ? Colon polyps ? Depression ? Dyspareunia ? Epicondylitis ? Fibromyalgia ? Hematuria ? Hyperlipemia ? Neuritis ? Obesity ? Polymyalgia (HCC) ? Pruritic dermatitis ? Psoriasis ? Psoriasis ? Sinus congestion
Allergies: NKDA
Diagnostic Lab Data: D-dimer 4.10 at 1500 on 1/20/21 Troponin neg. at 1500 on 1/20/21 Lipase 199 at 1500 on 1/20/21 BNP 18 at 1500 on 1/20/21 INR 1.0 at 1500 on 1/20/21 CMP and CBC - within normal limits CT results pending, ordering diagnosis : suspected PE s/p LTKA, +D-dimer, acute onset chest pain
CDC Split Type:

Write-up: Patient seated in observation area after vaccination at 1412. At 1422 patient reported feeling heaviness in chest rated at 7/10 pain scale, mandibular pain, appeared diaphoretic and fatigued, skin grey/pale, though remained alert and responsive to questions appropriately. Patient also communicates she was having some chest pain prior to the immunization today, though she indicated on her forms that she was feeling well today. Vital signs assessed, P72 R16 O2 99, patient denied difficulty breathing. Rapid response protocol initiated, applied 2L O2 via NC, transferred patient to wheelchair and taken to ED for evaluation by response team. ED assessment reveals calf tenderness and patient reporting TKA x 2 weeks ago, elevated D-Dimer, CT results pending at this time.


VAERS ID: 959492 (history)  
Form: Version 2.0  
Age: 31.0  
Sex: Female  
Location: Iowa  
Vaccinated:2021-01-12
Onset:2021-01-15
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-01-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL0142 / 2 LA / IM

Administered by: Work       Purchased by: ?
Symptoms: Computerised tomogram, Deep vein thrombosis, Fatigue, Laboratory test, Malaise, Pain in extremity, Pyrexia, Ultrasound Doppler, Ultrasound scan
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: CT, Doppler, Ultrasound, Labs
CDC Split Type:

Write-up: Employee received her 2nd Pfizer vaccine on 1/12/2021. Twelve hours after her vaccine she developed a fever with a T-max of 102 degrees. The fever lasted 18 hours. She also complained of severe malaise and fatigue lasting 36 hours. On day 3 (Friday, January 15, 2021) she developed left lower extremity pain that persisted over the weekend. She was seen in Urgent Care today where she was diagnosed with a deep vein thrombosis of the proximal vein. She also came to the ETC and was ruled out for a PE. The employee does have a family history of antiphospholipid in her mother. She has a follow up with her PCP and will also receive a work up in hematology as she had never been tested for any genetic coagulation conditions after her mom''s diagnosis.


VAERS ID: 959549 (history)  
Form: Version 2.0  
Age: 58.0  
Sex: Female  
Location: Missouri  
Vaccinated:2021-01-02
Onset:2021-01-13
   Days after vaccination:11
Submitted: 0000-00-00
Entered: 2021-01-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL0142 / UNK LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Acute myocardial infarction, Deep vein thrombosis, Dyspnoea, Electrocardiogram, Erythema, Intensive care, Laboratory test, Pulmonary embolism, Tenderness, X-ray
SMQs:, Anaphylactic reaction (narrow), Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Eliques; Cholecaleiferol; Ascorbic Acid; Calcium-Carbonate-Vitamin D; Coenzyme Q10; Ferrous Sulfate; Lisinopril; Magnesium Oxide; OxyCodone-Acetaminophen; Pantoprazole EC; Simvastatin; Vilazodone
Current Illness: Hip surgery 10/20
Preexisting Conditions: HTN; GERD; Back problems with left lower extremity numbness
Allergies: None
Diagnostic Lab Data: EKG Lab tests X-ray
CDC Split Type:

Write-up: 1/4/21- Patient stated she had tenderness on the back of her left lower leg with redness then 1/8/21 started to have shortness of breath and made a doctor''s appointment for 1/13/21. Seen by provider on 1/13/21 and was sent to ED and admitted to the hospital [ICU] with NSTEMI, acute deep, occlusive venous thrombosis left femoral vein and saddle embolus of pulmonary artery. Transferred to another acute care hospital for removal of thrombosis. Patient started on Eliqus and no intervention for removal of the thrombosis.


VAERS ID: 961282 (history)  
Form: Version 2.0  
Age: 49.0  
Sex: Female  
Location: Massachusetts  
Vaccinated:2020-12-29
Onset:2020-12-30
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-01-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ECO142 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Limb discomfort, Pain, Pain in extremity, Tenderness, Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ; ; VITAMIN C [CALCIUM ASCORBATE]; VITAMIN E [TOCOPHEROL]; VITAMIN B-12; ;
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Anemia; Blood pressure high; Depression; High cholesterol; Protein allergy (whey casium - slight allergy taking doxepin for it with relief)
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021021093

Write-up: Felt like a restless leg or blood clot but not as severe.; Felt like a restless leg or blood clot but not as severe.; Left below knee pain and discomfort. Some to the right leg as well.; Left below knee pain and discomfort. Some to the right leg as well.; Checked back of leg for warmth or bruising lasted day 2 and day 3.; Checked back of leg for warmth or bruising lasted day 2 and day 3.; Did feel some discomfort to left arm as a result of the shot in left arm, tender and could feel when holding arm up some discomfort; This is a spontaneous report from a contactable nurse reporting for herself. A 49-years-old female patient started to receive bnt162b2 (BNT162B2; Lot: ECO142) vaccine , intramuscular in the left arm on 29Dec2020 15:45 at single dose for Covid-19 immunisation . Medical history included hypertension, anaemia, blood cholesterol increased , depression, food allergy (whey casium) (taking doxepin for it with relief). Concomitant medication included doxepin (DOXEPIN), metoprolol (METOPROLOL), calcium ascorbate (VITAMIN C [CALCIUM ASCORBATE]), tocopherol (VITAMIN E [TOCOPHEROL]), cyanocobalamin (VITAMIN B-12) , atorvastatin (ATORVASTATIN), sertraline (SERTRALINE). The patient experienced felt like a restless leg or blood clot but not as severe. on 30Dec2020 07:00 with outcome of recovered , left below knee pain and discomfort. some to the right leg as well. on 30Dec2020 07:00 with outcome of recovered , checked back of leg for warmth or bruising lasted day 2 and day 3. on 30Dec2020 07:00 with outcome of recovered , did feel some discomfort to left arm as a result of the shot in left arm, tender and could feel when holding arm up some discomfort on 30Dec2020 07:00 with outcome of recovered. The event blood clot was considered serious (Important Medical Event). Course of the events The patient reported left below knee pain and discomfort. Some to the right leg as well. She checked back of leg for warmth or bruising lasted day 2 and day 3. She felt like a restless leg or blood clot but not as severe. She felt better to stand instead of sitting. Did feel some discomfort to left arm as a result of the shot in left arm, tender and could feel when holding arm up some discomfort. No shortness of breath, no nausea, no dizziness, no increased fatigue (baseline - not enough sleep - working 3 jobs).; Sender''s Comments: A possible contributory effect of suspect BNT162B2 on reported leg thrombosis cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.


VAERS ID: 961669 (history)  
Form: Version 2.0  
Age: 45.0  
Sex: Female  
Location: D.C.  
Vaccinated:2021-01-14
Onset:2021-01-15
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-01-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1284 / UNK LA / IM

Administered by: Work       Purchased by: ?
Symptoms: Burning sensation, Pain in extremity, Petechiae, SARS-CoV-2 test, SARS-CoV-2 test negative
SMQs:, Peripheral neuropathy (broad), Haemorrhage terms (excl laboratory terms) (narrow), Tendinopathies and ligament disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: plaquenil, leflunomide, restasis, pilocarpine, vitamin D, omega 3
Current Illness: none
Preexisting Conditions: Sjogren''s, raynaud
Allergies: sulfa, kiwi/pineapple, latex
Diagnostic Lab Data: My COVID PCR tests were negative on 1/15/2021, 1/12/2021, 1/8/2021, 1/4/2021, 12/11/2020, 12/4/2020, and 11/30/2020. Pending 1/21/2021 COVID PCR.
CDC Split Type:

Write-up: Since the 1/14/2021 Pfizer COVID vaccine, I had L 2nd MTP and R 3rd MTP burning sensation on 1/15/2021 (like I had foot blister or stubbed a toe). Then, I had petechiae with discoloration on 1/16/2021 and 1/17/2021. With my preexisting Raynaud, I believe the COVID toes again (pictures attached) are a COVID vaccine immunogenic response rather than COVID infection itself given my serial negative COVID PCR, absence of other symptoms, and only home/work social bubbles for $g 7 days. I have reported to Pfizer for vaccine adverse events.


VAERS ID: 961843 (history)  
Form: Version 2.0  
Age: 52.0  
Sex: Female  
Location: Virginia  
Vaccinated:2021-01-07
Onset:2021-01-08
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-01-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 LA / -

Administered by: Military       Purchased by: ?
Symptoms: Acute myocardial infarction, Catheterisation cardiac normal, Chest pain, Echocardiogram normal, Electrocardiogram abnormal, Fatigue, Myocardial infarction, Troponin increased
SMQs:, Myocardial infarction (narrow), Arrhythmia related investigations, signs and symptoms (broad), Embolic and thrombotic events, arterial (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Overweight
Preexisting Conditions: Medical History/Concurrent Conditions: Hashimoto''s thyroiditis; Vitiligo
Allergies:
Diagnostic Lab Data: Test Date: 202101; Test Name: cardiac catherization; Result Unstructured Data: Test Result:normal; Test Date: 202101; Test Name: echo; Result Unstructured Data: Test Result:normal; Test Date: 202101; Test Name: EKG; Result Unstructured Data: Test Result:abnormal; Test Date: 202101; Test Name: EKG; Result Unstructured Data: Test Result:Normal; Test Date: 20210108; Test Name: Troponin; Result Unstructured Data: Test Result:increased; Test Date: 20210109; Test Name: Troponin; Result Unstructured Data: Test Result:came down
CDC Split Type: USPFIZER INC2021030728

Write-up: Heart attack / she had a MI / diagnosed as a NSTEMI; This is a spontaneous report from a contactable healthcare professional (patient). This 52-year-old female patient received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) in left arm, on 07Jan2021, for COVID-19 vaccination. Medical history included autoimmune thyroiditis (Hashimoto''s thyroiditis) from 1998 and vitiligo from 1988. She was overweight. She had really no other risk factors. Concomitant medications were not reported. On 08Jan2021 the patient experienced heart attack and she had a MI, then a cardiac catherization that was normal and a normal echo as well. She said it was diagnosed as a NSTEMI and not a large MI, the smaller version. These events required hospitalization from 08Jan2021 to 12Jan2021. MI occurred after she finished clinic and she was not standing or doing anything, just sitting and she had chest pain. Her office was right next to the ER, so she received treatment within an hour and they were able to help her. She said that her hospital couldn''t do a cardiac cath, so on 11Jan2021 they moved her to an hospital which was another treatment facility. When she had her MI they gave her acetylsalicylic acid (ASPIRIN) and sublingual nitroglycerin. They tested her troponin and did an EKG which was abnormal on an unspecified date in Jan2021. On 08Jan2021 troponin was increased. When they treated her with nitroglycerin and Aspirin, two hours later her EKG was normal and her troponin came down overnight on 09Jan2021, which was when they said for sure that she had a heart attack. The patient said it was very scary to have a heart attack, but thankfully there was not a lot of damage done and she was able to get treatment quickly. She did not think the event was disabling since they did not see much damage to her heart muscle, it was a near miss kind of thing. She said it was life changing in that she will now be on medication forever, she will be on at least a baby Aspirin and probably something like a statin for the rest of her life. She was recovering, it was unknown what the lasting effects may be, she felt normal but tired from her hospital stay. Heart attack resolved on 08Jan2021. Information on the lot/batch number has been requested.; Sender''s Comments: Based on temporal association, the causal relationship between BNT162B2 and the event acute myocardial infarction cannot be excluded. The contributory role of the patient age and background of obesity cannot be excluded as well. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.


VAERS ID: 962169 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Unknown  
Vaccinated:2020-12-22
Onset:2020-12-22
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-01-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Chest pain, Coagulopathy, Fibrin D dimer increased, Injection site pain
SMQs:, Haemorrhage laboratory terms (broad), Extravasation events (injections, infusions and implants) (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Allergies:
Diagnostic Lab Data: Test Date: 202101; Test Name: Fibrin D dimer; Result Unstructured Data: Test Result:high
CDC Split Type: USPFIZER INC2021020831

Write-up: Clotting event; Fibrin D dimer high; chest pains; Little injection site soreness; This is a spontaneous report from a contactable consumer reporting for himself. A male patient of an unspecified age received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer -BioNTech), via an unspecified route of administration in the arm, on 22Dec2020, at single dose, for COVID-19 immunisation. Medical history was none. Concomitant medications were not reported. The patient experienced fibrin d dimer high in Jan2021 with outcome of unknown, clotting event on 03Jan2021 with outcome of unknown, chest pains on 03Jan2021 with outcome of unknown, little injection site soreness on 22Dec2020 with outcome of unknown. The events fibrin D dimer high and clotting event caused patient''s hospitalization in Jan2021. The patient underwent lab tests and procedures which included fibrin d dimer: high in Jan2021. The patient was vaccinated on 22Dec2020 close to the evening and had a normal response with a little soreness in the arm at the injection site. Then on 03Jan2021, he reported to be having chest pains that he never had before and went to the emergency department (ED) due to a clotting event. Upon blood work, they discovered that his D-dimer was elevated and was really high for his age. He mentioned that he had no history and no issues with this whatsoever before. He received the 2nd dose on 11Jan2021. The information on the lot/batch number has been requested.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=10&SYMPTOMS[]=Cerebral_venous_sinus_thrombosis_%2810083037%29&SYMPTOMS[]=Cerebral_venous_thrombosis_%2810008138%29&SYMPTOMS[]=Coagulopathy_%2810009802%29&SYMPTOMS[]=Deep_vein_thrombosis_%2810051055%29&SYMPTOMS[]=Disseminated_intravascular_coagulation_%2810013442%29&SYMPTOMS[]=Embolism_%2810061169%29&SYMPTOMS[]=Idiopathic_thrombocytopenic_purpura_%2810021245%29&SYMPTOMS[]=Immune_thrombocytopenia_%2810083842%29&SYMPTOMS[]=Immune_thrombocytopenic_purpura_%2810074667%29&SYMPTOMS[]=Ischaemic_stroke_%2810061256%29&SYMPTOMS[]=Myocardial_infarction_%2810028596%29&SYMPTOMS[]=Petechiae_%2810034754%29&SYMPTOMS[]=Pulmonary_embolism_%2810037377%29&SYMPTOMS[]=Purpura_%2810037549%29&SYMPTOMS[]=Thrombocytopenia_%2810043554%29&SYMPTOMS[]=Thrombosis_%2810043607%29&SYMPTOMS[]=Vasculitis_%2810047115%29&VAX=COVID19&VAXMAN=PFIZER/BIONTECH


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166